Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 1573

   Table of Contents     
Year : 2011  |  Volume : 4  |  Issue : 2  |  Page : 102-103

Hyperprolactinemia: An often missed cause of male infertility

1 Departments of Obstetrics and Gynecology, JIPMER, Puducherry, India
2 Department of Neurosurgery, JIPMER, Puducherry, India
3 Department of Neurosurgery, Dr. Achanta Lakshmipathi Neurosurgical Center, Postgraduate Institute of Neurological Surgery, V.H.S. Hospital, Taramani, Chennai, India
4 Department of Neurology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

Date of Web Publication15-Oct-2011

Correspondence Address:
Pratibha Singh
Department of Obstetrics & Gynaecology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Dhanvantri Nagar, Puducherry - 605 006
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0974-1208.86094

Rights and Permissions


How to cite this article:
Singh P, Singh M, Cugati G, Singh AK. Hyperprolactinemia: An often missed cause of male infertility. J Hum Reprod Sci 2011;4:102-3

How to cite this URL:
Singh P, Singh M, Cugati G, Singh AK. Hyperprolactinemia: An often missed cause of male infertility. J Hum Reprod Sci [serial online] 2011 [cited 2022 Aug 17];4:102-3. Available from:


Prolactinoma is the most common tumor of pituitary gland, comprising up to 45% of all pituitary tumors. [1] Prolactinoma is the most common cause of hyperprolactinemia, which is a common cause of infertility in males and females. [1],[2] Clinical presentation of the prolactinomas are earlier in females compared with males, even when they are very small (microadenoma). [1],[2] This earlier presentation in females is due to greater symptom burden caused by hyperprolactinemia in them. [1] On the other hand, males present late till prolactinoma becomes large in size (macroprolactinoma) and start causing pressure over optic chiasm and presented as visual deterioration or visual field defects. They can also present with decreased libido. [1] So clinical diagnosis of prolactinoma in male patents is late, which can lead to misdiagnosis of microprolactinoma in male patients. [2]

Hyperprolactinemia causes infertility in around 11% of oligospermic males. [3] Hyperprolactinemia inhibits the pulsatile secretion of the gonadotrophin releasing hormone, which causes decreased pulsatile release of follicle stimulating hormone, luteinizing hormone, and testosterone, which in turn causes spermatogenic arrest, impaired sperm motility, and altered sperm quality. [3] It later produces secondary hypogonadism and infertility. [3] Hyperprolactinemia also directly influences spermatogenesis and steroidogenesis by acting on prolactin receptors present in  Sertoli cells More Details and Leydig cells in testes, and produces primary hypogonadism and infertility. [3] It is seen that oligospermic or azoospermic patients with normal serum levels of gonadotrophins show relatively higher serum levels of prolactin, proving a role of prolactin in gametogenesis, which is independent of gonadotrophins. [3],[5] There are many studies suggesting that hyperprolactinemia has a definite role in the male infertility, and is one of the reversible causes of infertility. [2],[3],[4],[5] It can be managed medically with simple medication, such as bromocriptine and cabergoline, which normalizes serum prolactin levels, restoration of gonadal function, reversing infertility caused by hyperprolactinemia and induces reduction in the prolactinoma size in the majority of patients. [2],[4],[6]

It is a common and reversible cause of male infertility, and has excellent results with dopamine agonist drugs. [2],[4],[6] Misdiagnosis of hyperprolactinemia in male can lead to irreversibility of this condition and may lead toward unnecessarily expansive procedures, such as in vitro fertilization (IVF) for achieving pregnancies. In infertility clinic, if male patients present with decreased libido, erectile dysfunction, and hypogonadism, and semen microscopic analysis shows oligospermia or azoospermia, impaired sperm motility, or altered sperm quality, a routine evaluation of serum prolactin level should be done, which can avoid unnecessary, costly, and invasive investigation (eg, testicular biopsy) for evaluation of male infertility. [2],[3],[4],[5],[6]

Hyperprolactinemia is a common cause of infertility in males but the latest European guidelines published in European Urology 2005 and revised in 2010 for evaluation of male infertility has not included the hormonal assessment of the serum prolactin level during evaluation of male infertility. [7]

After reviewing the literature, a routine evaluation of the serum prolactin level should be done in male infertility cases and included in the guideline for evaluation of male infertility. This will prevent misdiagnosis of hyperprolactinemia, avoid unnecessary costly investigations, and guide toward appropriate management to achieve pregnancy.

   References Top

1.Ciccarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas. none Pituitary 2005;8:3-6.  Back to cited text no. 1
2.Buvat J. Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res 2003;15:373-7.  Back to cited text no. 2
3.Masud S, Mehboob F, Bappi MU. Severe hyperprolactinemia directly depresses the gonadal activity causing infertility. Esculapio J Services Inst Med Sci 2007;2:25-7.  Back to cited text no. 3
4.De Rosa M, Zarrilli S, Di Sarno A, Milano N, Gaccione M, Boggia B, et al. Hyperprolactinemia in men: Clinical and biochemical features and response to treatment. Endocrine 2003;20:75-82.  Back to cited text no. 4
5.Soler Fernández JM, Caravaca Magariños F, Domínguez Bravo C, Murillo Mirat J, Aparicio Palomino A, Herrera Puerto J. Correlation of serum prolactin, sperm count and motility. Prevalence of hyperprolactinemia in the infertile male. Arch Esp Urol 1990;43:891-5.  Back to cited text no. 5
6.Laufer N, Yaffe H, Margalioth EJ, Livshin J, Ben-David M, Schenker JG. Effect of bromocriptine treatment on male infertility associated withhyperprolactinemia. Arch Androl 1981;6:343-6.  Back to cited text no. 6
7.Dohle GR, Colpi GM, Hargreave TB, Papp GK, Jungwirth A, Weidner W. EAU Guidelines on male infertility. Eur Urol 2005;48:703-11.  Back to cited text no. 7

This article has been cited by
1 Bromocriptine therapy: Review of mechanism of action, safety and tolerability
Faiza Naz, Abdul Malik, Muhammad Riaz, Qaisar Mahmood, Malik Hassan Mehmood, Ghulam Rasool, Zahed Mahmood, Mazhar Abbas
Clinical and Experimental Pharmacology and Physiology. 2022;
[Pubmed] | [DOI]
2 Male factor infertility: A contemporary overview of investigation, diagnosis and management
Anil Krishan, Josip Vukina, Ian Pearce, Vaibhav Modgil
Journal of Clinical Urology. 2022; : 2051415822
[Pubmed] | [DOI]
3 The Fate of Leydig Cells in Men with Spermatogenic Failure
Daria Adamczewska, Jolanta Slowikowska-Hilczer, Renata Walczak-Jedrzejowska
Life. 2022; 12(4): 570
[Pubmed] | [DOI]
4 Persistent idiopathic prolactin elevation merits macroprolactin estimation: A case report and review of literature
Krishnaprabha Gautam, KripaElizabeth Cherian, Arun Jose, TK Aleyamma, Nitin Kapoor, ThomasVizhalil Paul
Journal of Human Reproductive Sciences. 2021; 14(2): 206
[Pubmed] | [DOI]
5 Endocrinopathies and Male Infertility
Pallav Sengupta, Sulagna Dutta, Ivan Rolland Karkada, Suresh V. Chinni
Life. 2021; 12(1): 10
[Pubmed] | [DOI]
6 Evaluation of the effect of vitamin D supplementation on spermatogram, seminal and serum levels of oxidative stress indices in asthenospermia infertile men: a study protocol for a triple-blind, randomized controlled trial
Leila Maghsoumi-Norouzabad, Ahmad Zare Javid, Anahita Mansoori, Mohammadreza Dadfar, Amirarsalan Serajian
Nutrition Journal. 2021; 20(1)
[Pubmed] | [DOI]
7 The effects of Vitamin D3 supplementation on Spermatogram and endocrine factors in asthenozoospermia infertile men: a randomized, triple blind, placebo-controlled clinical trial
Leila Maghsoumi-Norouzabad, Ahmad Zare Javid, Anahita Mansoori, Mohammadreza Dadfar, Amirarsalan Serajian
Reproductive Biology and Endocrinology. 2021; 19(1)
[Pubmed] | [DOI]
8 A Review on Male Infertility - Environmental Factors, Pathophysiological and Oxidative Stress
Lata Kanyal Butola, Archana Dhok, Deepika Kanyal, Anjali Vagga
Journal of Evolution of Medical and Dental Sciences. 2021; 10(44): 3798
[Pubmed] | [DOI]
9 Morbid Obesity Due to Prolactinoma and Significant Weight Loss After Dopamine Agonist Treatment
Muzaffar Ali, Lubna Mirza
AACE Clinical Case Reports. 2021; 7(3): 204
[Pubmed] | [DOI]
10 Prevalence of Hyperprolactinemia and Clinically Apparent Prolactinomas in Men Undergoing Fertility Evaluation
Siddhant S. Ambulkar, Anne L. Darves-Bornoz, Richard J. Fantus, James Wren, Nelson E. Bennett, Joshua A. Halpern, Robert E. Brannigan
Urology. 2021;
[Pubmed] | [DOI]
11 Yishentongluo decoction in treatment of idiopathic asthenozoospermia infertility
Qi Zhang, Lipeng Fan, Fangyuan Li, Zixue Sun, Chenming Zhang, Rubing Chen
Medicine. 2020; 99(43): e22662
[Pubmed] | [DOI]
12 The Role of Prolactin and the Diagnostic Value of Hyperprolactinemia in Men
?. ?. ???????????, ?. ?. ????????????
Health of Man. 2019; 0(1): 6
[Pubmed] | [DOI]
13 Clinical implications of measuring prolactin levels in males of infertile couples
F. Lotti,G. Corona,E. Maseroli,M. Rossi,A. Silverii,S. DeglæInnocenti,G. Rastrelli,G. Forti,M. Maggi
Andrology. 2013; 1(5): 764
[Pubmed] | [DOI]


Print this article  Email this article


    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Article in PDF (373 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded336    
    Comments [Add]    
    Cited by others 13    

Recommend this journal